Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as Clinical and Translational Science Associate Editor Sonal Singh and Guest Editor Zachary Taylor discuss the open Biomarkers Call for Papers and what themes they’d like to see covered in this upcoming special collection, as well as the deadline for submission.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related